Republicans are calling for answers after news broke that the federal government limited use of a key COVID treatment.
The Food and Drug Administration announced this week they are limiting the use of certain monoclonal antibody treatments, the latest controversial decision by the federal government, which took over distribution of the treatment.
“The Biden administration’s track record on COVID is a disgrace,” said Sen. Ted Cruz, R-Texas. “They’ve consistently politicized health and medicine, denying Texans and Americans live-saving treatments. After months of rationing critical antibody therapies, they now entirely pulled the approvals. Enough is enough. It’s time for the FDA and the Biden administration to put the interests of patients first and to stop politicizing COVID.”
Cruz sent a letter to the FDA demanding answers:
- Identify who specifically decided to limit the use of these monoclonal antibodies to treat COVID-19.
- What was the reason for limiting the use of these monoclonal antibodies’ treatments on January 24th, 2022 allegedly due to Omicron, when the first confirmed U.S. case of Omicron was on December 1, 2021?
- Is there a possibility of a new COVID-19 variants emerging? If so, why would the FDA limit access to these treatments now when they could be highly effective against other future-emerging variants?
The federal governemnt has taken heavy fire for its rationing of the treatment and publicly saying that minorities will be given preferential access to the life-saving care.
“The Biden Administration’s decision to revoke access to monoclonal antibodies was made with complete and utter disregard for the thousands of sick Floridians who were left scrambling to find an alternative treatment,” said Gov. Ron DeSantis. “These Floridians should be able to access these treatments.”
Want more? Check out Trish Regan’s podcast HERE.
